Posts

Showing posts from October, 2019

Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire

Image
Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire Posted: 31 Oct 2019 06:30 AM PDT LONDON--( BUSINESS WIRE )--Technavio's report on human papillomavirus (HPV) therapeutics market is expected to grow by $1.75 billion during 2019-2023 . Currently, the approved vaccines for HPV therapies are administered through the parenteral route, which needs an invasive infusion of therapeutics into the body. To meet the need for novel drug delivery systems, vendors are working on developing oral vaccines for HPV. These vaccines are developed with nano or microparticles around the surface to enhance target delivery. This will lead to a rise in patient adherence to the treatment and attract more people to accept the vaccines. Read ...

65.7% of Scottish Men Embrace Cancer Prevention Vaccination - Vax Before Travel

Image
65.7% of Scottish Men Embrace Cancer Prevention Vaccination - Vax Before Travel 65.7% of Scottish Men Embrace Cancer Prevention Vaccination - Vax Before Travel Posted: 30 Oct 2019 02:48 PM PDT Since the human papillomavirus (HPV) vaccine first became available to men in Scotland, about 65.7 percent have been immunized. The new data from the Information Services Division (ISD) Scotland shows that about 14,000 eligible men attended a health clinic between July 2017 and June 2019.  Of those men, 9,146 received at least 1-dose of the HPV vaccine called Gardasil. The majority of these men were between the ages of 20 to 29. The Gardasil (Gardasil 4vHPV) vaccine protects against HPV, which is a sexually transmitted virus that causes the majority of cervical cancer cases in women. Additionally, the HPV virus causes cancers of the genitals, throat, and mouth. Earlier in 2019, researchers found the routine vaccination of Scottish girls aged 12-1...

Health

Image
Health Premium Hemp Oil Extract for Pain Relief, Anxiety, Sleep (PURE, NATURAL) - 4oz SOUTHWEST 1 EA Elasto-Gel Hot/Cold Wrap 9" x 24" TW6010 CHOP UNIQUE WELLNESS 1 CA/60 EA Brief Super Absorbent X-Large 47" - 67" 3155 CHOP Ascensia Contour Blood Glucose Monitoring System Diabetes Meter CHOP HEMAWAY 1 EA Fast Relief Hemorrhoid Cream TC1 CHOP CONVATEC SAF-Clens AF Dermal Wound Cleanser 12oz 6-Pack Case CHOP UNIQUE WELLNESS 1 CA/72 EA Absorbent Underwear Medium 19" to 30" Waist CHOP Black Pop Up Airbrush Makeup Sunless Over Spray Tanning Tent Booth Waterproof Premium Hemp Oil Extract for Pain Relief, Anxiety, Sleep (PURE, NATURAL) - 4oz Posted: 31 Oct 2019 12:00 AM PDT {"itemId":223541356047,"title":"Premium Hemp Oil Extract for Pain Relief, Anxiety, Sleep (PURE, NATURAL) - 4oz","endsAt":"2019-11-05T03:52:13.000Z",...

Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire

Image
Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire Posted: 31 Oct 2019 06:30 AM PDT LONDON--( BUSINESS WIRE )--Technavio's report on human papillomavirus (HPV) therapeutics market is expected to grow by $1.75 billion during 2019-2023 . Currently, the approved vaccines for HPV therapies are administered through the parenteral route, which needs an invasive infusion of therapeutics into the body. To meet the need for novel drug delivery systems, vendors are working on developing oral vaccines for HPV. These vaccines are developed with nano or microparticles around the surface to enhance target delivery. This will lead to a rise in patient adherence to the treatment and attract more people to accept the vaccines. Read ...

Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire

Image
Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire HPV immunization program cuts pre-cancer rates by more than half - Science Daily Scientists uncover major cervical cancer breakthrough - New York Post Cannabis And HPV: A Treatment Or A Cause? - The Fresh Toast Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire Posted: 31 Oct 2019 06:30 AM PDT LONDON--( BUSINESS WIRE )--Technavio's report on human papillomavirus (HPV) therapeutics market is expected to grow by $1.75 billion during 2019-2023 . Currently, the approved vaccines for HPV therapies are administered through the parenteral route, which need...